The orphan receptor GPRC5B promotes macrophage infiltration and an inflammatory plaque phenotype in atherosclerosis

Greta Verena Freundt1, Friedrich Alexander von Samson-Himmelstjerna1, Jan-Thorge Nitz1

  • 1Department of Cardiology and Angiology, University Hospital Schleswig-Holstein, Campus Kiel, Christian-Albrechts-Universität zu Kiel, Arnold-Heller-Str. 3, D-24105 Kiel, Germany.

Abstract

Insights

Overexpression of G protein-coupled receptor GPRC5B in macrophages promotes plaque inflammation and macrophage infiltration in atherosclerosis. This suggests GPRC5B may be a therapeutic target for vascular inflammation.

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Molecular Biology

Background:

  • Atherosclerosis involves chronic vascular wall inflammation with macrophages playing a key role.
  • G protein-coupled receptor GPRC5B (GPRC5B) is present in vascular cells and macrophages, increasing during differentiation.
  • GPRC5B activates inflammatory pathways in adipose tissue and glomeruli.

Purpose of the Study:

  • To investigate the role of GPRC5B in macrophage infiltration.
  • To determine the impact of GPRC5B on atherosclerotic plaque progression in vivo.

Main Methods:

  • Bone marrow from GPRC5B-transgenic and wild-type mice was transplanted into LDL receptor-deficient mice.
  • Mice were fed a Western-type diet for 16 weeks.
  • Atherosclerotic lesions in the aortic sinus were analyzed.

Main Results:

  • No significant differences in serum lipids or cardiac mass were observed.
  • GPRC5B-transgenic mice showed significantly increased macrophage infiltration in plaques.
  • A trend towards larger and more complex lesions was noted.

Conclusions:

  • GPRC5B overexpression enhances macrophage infiltration, promoting a more inflammatory plaque phenotype.
  • GPRC5B is a potential modulator of atherosclerotic plaque progression.
  • GPRC5B may serve as a novel therapeutic target for vascular inflammation.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
61.6K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
916
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
110.5K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.9K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
367
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.3K